No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
Incidence of fatigue, chronic fatigue increased significantly after COVID-19 infection
Feb 21, 2024
An increased risk was seen for fatigue and chronic fatigue, with hazard ratios of 1.68 and 4.32 compared with non-COVID-19 controls.
Air pollution linked to worse outcomes for COVID-19 patients
Jun 26, 2023
“This article reinforces the evidence that community intervention on air pollution abatement would be a very effective way to protect our population from the impact of COVID-19, with the co-benefit...
CDC: Monitoring of COVID-19 will remain a priority
May 08, 2023
Surveillance of COVID-19 and COVID-19-associated mortality after expiration of the COVID-19 public health emergency declaration on May 11 will continue.
Venous thromboembolism risk low in COVID-19 outpatients
Mar 20, 2023
Patient-level factors, including age, sex and body mass index, were associated with a higher risk.
Immunoglobulin G spike receptor binding domain antibody levels were similar after the primary series and booster dose.
Child care stress affects health, work of U.S. healthcare workers during pandemic
Jul 22, 2022
High child care stress was tied to anxiety, depression and burnout as well as retention issues.
Simultaneous flu vaccine, COVID-19 booster safe
Jul 21, 2022
Systemic reactions generally were mild and were slightly more likely among those receiving both vaccines compared with the COVID-19 mRNA booster alone.
Fourth COVID-19 vaccine dose safe for immunocompromised
Jul 18, 2022
Local and systemic reactions were reported less frequently after the fourth dose versus dose 3 of the primary vaccination series.